✦ LIBER ✦

Risk of Cardiovascular Events in Patients Receiving Celecoxib: A Meta-Analysis of Randomized Clinical Trials

✍ Scribed by William B. White; Christine R. West; Jeffrey S. Borer; Philip B. Gorelick; Lisa Lavange; Sharon X. Pan; Ethan Weiner; Kenneth M. Verburg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone and cardiovascular risk. A

✍ E. Mannucci; M. Monami; C. Lamanna; G. F. Gensini; N. Marchionni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Effect of metformin on cardiovascular ev

✍ C. Lamanna; M. Monami; N. Marchionni; E. Mannucci 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Dipeptidyl peptidase-4 inhibitors and ca

✍ M. Monami; B. Ahrén; I. Dicembrini; E. Mannucci 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

Cardiovascular safety of sulfonylureas:

✍ Monami, M.; Genovese, S.; Mannucci, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Atherosclerotic coronary plaque regressi

✍ D'Ascenzo, Fabrizio; Agostoni, Pierfrancesco; Abbate, Antonio; Castagno, Davide; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 663 KB

Challenges in meta-analysis of randomize

✍ Adrian V. Hernandez; Esteban Walker; John P.A. Ioannidis; Michael W. Kattan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 191 KB